Welcome to the Novartis portal for UK healthcare professionals (HCPs) and other relevant decision makers*, where you can find promotional information about Novartis products, therapy area materials and professional resources.
*Other relevant decision makers particularly includes those with an NHS role who could influence in any way the administration, consumption, prescription, purchase, recommendation, sale, supply or use of any medicine but who are not health professionals.
This site is intended for UK healthcare professionals and other relevant decision makers only. If you are a member of the public, please click here
This video series focuses on the key unmet needs in chronic myeloid leukaemia (CML). In this series we are joined by a host of international experts who provide their perspectives on resistance to tyrosine kinase inhibitors (TKIs), the impact of intolerance on patients and the potential consequences of sequential TKIs use. The series aims to shine a light on how healthcare professionals can...Show more
Drawing on leading practitioner and academic insights, the following webinars are designed to inform and support the treatment and care of patients with chronic myeloid leukaemia (CML).Show more
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]